17Aug
An Update on Poison Pills, NOL Poison Pills and the COVID-19 Pandemic
Since the release of our recent article “Poison Pills, NOL Poison Pills and the COVID-19 Pandemic” in midApril, we continue to see a surge in the number of companies implementing poison pills (also referred to as shareholder rights plans), a type of defensive tactic used by a corporation’s board of directors against a hostile takeover bid. Please see full Publication below for more information....
By:
Robinson & Cole LLP
Related
On January 28, 2020, the Federal Trade Commission (FTC) announced revised jurisdictional thresholds ...
Read More >
On 13 December 2019 the U.S. Department of Justice's (DOJ) National Security Division (NSD) announce...
Read More >
Many of the provisions of the Setting Every Community Up for Retirement Enhancement Act of 2019 (the...
Read More >
Companies must mitigate risks to antitrust privilege posed by cross-border megadeals and increased r...
Read More >
This is an update to previous posts from June 24, 2019 and July 31, 2019. On Friday, November 22, B...
Read More >
En el contexto de la emergencia sanitaria causada por COVID-19 en Colombia, el Gobierno Nacional emi...
Read More >